WHO ICTRP trial

Comparison ofMidasolam-meperidine and Propofol -Fentanyl sedation in patients…

IRCT201301235381N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT201301235381N5
Public title Comparison ofMidasolam-meperidine and Propofol -Fentanyl sedation in patients scheduled for colonoscopy
Scientific title Comparison ofMidasolam-meperidine and Propofol -Fentanyl sedation in patients scheduled for colonoscopy
Primary sponsor Mazandaran Uiversity of Medical Sciences and Health Services
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 2-3
Countries Iran (Islamic Republic of)
Conditions Patients with intestine diseases who need colonoscopy. disease of intestine,unspecified;disease of intestine,unspecified
Interventions Intervention 1: Fentanil 1microgram/kg and bolus dose of propofol 0.5 mg/kg was given, followed by continuous infusion at 25microgram/kg/min. Intervention 2: midasolam 0.3mg/kg and meperidine 0.7mg/kg was adminstrated by bolus…
Registration date May 11, 2013
Target size 80
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations